Evaluation of Xpert MTB/RIF Ultra on airborne infection isolation duration in a low tuberculosis prevalence setting

Key Points

• This research aims to assess the effect of Xpert MTB/RIF Ultra on the duration of airborne infection isolation.
• Evaluation of Xpert MTB/RIF Ultra in a low tuberculosis prevalence setting
• Assessment of isolation duration in patients suspected of pulmonary tuberculosis.
• Real-world evidence collection on the operational impact of the diagnostic tool.
• Xpert MTB/RIF Ultra demonstrated a reduction in airborne infection isolation duration.
• Operational impact is evaluated specifically in low prevalence tuberculosis settings.